Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effectiveness of personalised surveillance and aftercare in breast cancer follow-up: a systematic review.
van Maaren MC, van Hoeve JC, Korevaar JC, van Hezewijk M, Siemerink EJM, Zeillemaker AM, Klaassen-Dekker A, van Uden DJP, Volders JH, Drossaert CHC, Siesling S; NABOR project group. van Maaren MC, et al. Among authors: van hezewijk m. Support Care Cancer. 2024 May 2;32(5):323. doi: 10.1007/s00520-024-08530-2. Support Care Cancer. 2024. PMID: 38695938 Free PMC article.
Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model.
Völkel V, Hueting TA, Draeger T, van Maaren MC, de Munck L, Strobbe LJA, Sonke GS, Schmidt MK, van Hezewijk M, Groothuis-Oudshoorn CGM, Siesling S. Völkel V, et al. Among authors: van hezewijk m. Breast Cancer Res Treat. 2021 Oct;189(3):817-826. doi: 10.1007/s10549-021-06335-z. Epub 2021 Aug 2. Breast Cancer Res Treat. 2021. PMID: 34338943 Free PMC article.
The use and misuse of risk prediction tools for clinical decision-making.
van Maaren MC, Hueting TA, Völkel V, van Hezewijk M, Strobbe LJ, Siesling S. van Maaren MC, et al. Among authors: van hezewijk m. Breast. 2023 Jun;69:428-430. doi: 10.1016/j.breast.2023.01.006. Epub 2023 Jan 21. Breast. 2023. PMID: 36709092 Free PMC article. No abstract available.
The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy.
Van Maaren MC, Hueting TA, van Uden DJP, van Hezewijk M, de Munck L, Mureau MAM, Seegers PA, Voorham QJM, Schmidt MK, Sonke GS, Groothuis-Oudshoorn CGM, Siesling S; NABOR project group. Van Maaren MC, et al. Among authors: van hezewijk m. Breast. 2024 Oct 28;79:103829. doi: 10.1016/j.breast.2024.103829. Online ahead of print. Breast. 2024. PMID: 39541608 Free PMC article.
Feasibility of tailored follow-up for patients with early breast cancer.
van Hezewijk M, Smit DJ, Bastiaannet E, Scholten AN, Ranke GM, Kroep JR, Marijnen CA, van de Velde CJ. van Hezewijk M, et al. Among authors: van de velde cj. Breast. 2014 Dec;23(6):852-8. doi: 10.1016/j.breast.2014.09.002. Epub 2014 Oct 28. Breast. 2014. PMID: 25438712
20 results